Similar results are observed in IgA reactivity to glycolipid antigen after 2 and 6 months during anti-TB therapy, suggesting a potential role for antigen-specific IgA in monitoring pulmonary TB treatment (Bezerra et al., 2009). Here, CD79A is linked to pulmonary tuberculosis.